Prime Medicine, Inc. - COMMON STOCK (PRME)

Historical Holders from Q4 2022 to Q3 2025

Symbol
PRME on Nasdaq
CUSIP
74168J101
Type / Class
Equity / COMMON STOCK
Shares outstanding
174M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
92.1M
Holdings value
$510M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
160
Number of buys
112
Number of sells
-37
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prime Medicine, Inc. - COMMON STOCK (PRME)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund XII, L.P. 10.4% $23.6M 18.6M Robert Nelsen Aug 7, 2025
GV 2019, L.P. 12.3% $91.8M 16.6M Alphabet Holdings LLC Sep 30, 2025
T. Rowe Price Investment Management, Inc. 5.3% $51.2M 9.24M T. Rowe Price Investment Management, Inc. Sep 30, 2025
FMR LLC 3.8% $37.3M 6.73M FMR LLC Sep 30, 2025
Newpath Partners, L.P. 4.7% $7.14M 6.11M Newpath Partners, L.P. Dec 31, 2024

Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 92.1M $510M +$187M $5.54 160
2025 Q2 58.7M $145M -$2.52M $2.47 119
2025 Q1 60.3M $120M -$9.14M $1.99 121
2024 Q4 64.3M $188M -$16.4M $2.92 128
2024 Q3 68.7M $266M -$1.69M $3.87 113
2024 Q2 68.9M $354M +$8.57M $5.14 119
2024 Q1 66.7M $467M +$126M $7.00 112
2023 Q4 16.2K $143K $8.86 1
2023 Q3 49.5M $472M +$28.5M $9.54 82
2023 Q2 46.1M $676M +$67.1M $14.65 77
2023 Q1 41.7M $512M +$3.23M $12.30 73
2022 Q4 41.3M $768M +$767M $18.58 65